跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,980 条关于
“Rafael Pharmaceuticals”
全部
8,980
临床试验
551
药物
1,732
机构
2,062
资讯
4,635
4年前
EMA Grants Orphan Drug Designation to Devimistat for Refractory Burkitt's Lymphoma
去年
Rafael Holdings Completes $25 Million Rights Offering to Fund Trappsol Cyclo Phase 3 Trial for Rare Disease
5个月前
Rafael Holdings Secures Exclusive MIT License for Cyclodextrin Therapy Targeting ApoE4-Positive Alzheimer's Patients
去年
Mayo Clinic's Dr. Rafael Fonseca: Pioneering Multiple Myeloma Research and Treatment Revolution
去年
Rafael Holdings Reports 78% Success Rate for NPC1 Treatment in Phase 3 Pediatric Sub-Study
去年
Protara Therapeutics Appoints William Conkling as Chief Commercial Officer to Lead Commercialization Strategy
去年
HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)
去年
Bora Pharmaceuticals Acquires Pyros Pharmaceuticals, Expanding Rare Disease Portfolio
去年
Zai Lab to Present Phase 1 Data on Novel DLL3-Targeted ADC for Small Cell Lung Cancer at ASCO 2025
去年
MIRA Pharmaceuticals to Acquire SKNY Pharmaceuticals, Expanding into $200 Billion Weight Loss and Smoking Cessation Markets
第 1 页,共 464 页
上一页
下一页